Study of OTO-104 in Subjects With Unilateral Meniere's Disease

NCT02612337 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

166

Enrollment

INDUSTRY

Sponsor class

Conditions

Meniere's Disease

Interventions

DRUG: OTO-104
DRUG: Placebo

Sponsor

Otonomy, Inc.